| 前收盘价格 | 135.15 |
| 成交量 | 132,252 |
| 价格/销量 (P/S) | 5.00 |
| 股市价格/股市净资产 (P/B) | 3.08 |
| 52周波幅 |
| 营业毛利率 | 7.42% |
| 营业利益率 (TTM) | 12.84% |
| 稀释每股收益 (EPS TTM) | 1.95 |
| 季度收入增长率 (YOY) | 1.10% |
| 季度盈利增长率 (YOY) | 44.50% |
| 总债务/股东权益 (D/E MRQ) | 57.49% |
| 流动比率 (MRQ) | 2.56 |
| 营业现金流 (OCF TTM) | 157.37 M |
| 杠杆自由现金流 (LFCF TTM) | 152.43 M |
| 资产报酬率 (ROA TTM) | 5.75% |
| 股东权益报酬率 (ROE TTM) | 9.73% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Scientific & Technical Instruments (US) | 混合的 | 看涨 |
| Scientific & Technical Instruments (全球的) | 混合的 | 看涨 | |
| 股票 | Novanta Inc. | 混合的 | 混合的 |
AIStockmoo 评分
| 价值 35% | -1.9 |
| AI Insight 参考 | NA |
| 相对估值 参考 | -5.0 |
| 财务健康 参考 | 2.8 |
| 时机 35% | -2.1 |
| AI Technical 参考 | NA |
| 技术振荡指标 参考 | -3.5 |
| 技术平均移动指标 参考 | 0.0 |
| 聪明钱 30% | 0.0 |
| 分析师共识 参考 | 0.0 |
| 内部交易活动 参考 | NA |
| 市场环境 | ×1.21 |
| 宏观环境 参考 | -3.3 |
| 行业对比大市 (6个月) | -21.2% |
| 支柱一致性 | ×1.25 |
| 不计入评分 | |
| 价格波动 参考 | -2.0 |
| 最终评分 | -2.11 |
|
Novanta Inc supplies core technology solutions to medical, life science, and advanced industrial OEMs, leveraging proprietary expertise in precision medicine, precision manufacturing, robotics and automation, and advanced surgery. It has two segments: Automation Enabling Technologies and Medical Solutions. Automation Enabling Technologies, which generates the majority of revenue, provides laser beam steering and scanning solutions, laser sources, and robotic and precision motion technologies. The Medical Solutions segment provides medical-grade technologies, including medical insufflators, endoscopic pumps, and integrated operating room technologies. The company operates in the United States, Germany, and other markets, with revenue generated from the United States. |
|
| 部门 | Technology |
| 行业 | Scientific & Technical Instruments |
| 投资方式 | Small Growth |
| 内部持股比例 | 0.86% |
| 机构持股比例 | 105.06% |
该时间范围内无数据。
该时间范围内无数据。
投资组合